Banco de Sabadell’s Zimmer Biomet ZBH Stock Holding History

Banco de Sabadell’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,963	Closed	-$3.27M	–	297
2021 Q1	$3.27M	Buy	20,963 +164	+0.8%	+$25.4K	0.34%	80
2020 Q4	$3.09M	Buy	+20,799	New	+$2.94M	0.33%	86
2019 Q1	–	Sell	-9,358	Closed	-$937K	–	434
2018 Q4	$937K	Buy	+9,358	New	+$1.05M	0.11%	173

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Banco de Sabadell's ZBH Position: Q2 2021 in Review

Banco de Sabadell sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 20,963 shares — an estimated $3.27M sold.

Banco de Sabadell first reported a position in ZBH in Q4 2018 and held it in 3 quarters. The position peaked at $3.27M in Q1 2021. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

Banco de Sabadell reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
Banco de Sabadell sold 20,963 Zimmer Biomet shares in Q2 2021, an estimated $3.27M.
Banco de Sabadell first reported a position in Zimmer Biomet in Q4 2018 and held it in 3 quarters.
Banco de Sabadell's Zimmer Biomet position peaked at $3.27M in Q1 2021.
1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Banco de Sabadell's 13F filing for Q2 2021, filed 13 Aug 2021.